Indian Institute of Science Education and Research Kolkata  IISER Kolkata was established in 2006 by the Ministry of Human Resource Development (MHRD), Government of India. IISER Kolkata is designed to reach the prestigious position in the global setting that IISc, IIMs and IITs presently enjoy. IISER Kolkata is an autonomous institution awarding its own degrees. The central theme of the IISER Kolkata is to integrate education with research so that undergraduate teaching as well as doctoral and postdoctoral research work could be carried out in symbiosis.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in markets across emerging economies including India. The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 65 countries including the US, various countries in the EU, South America and India.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms.

Gilead Sciences, Inc announced that in response to the rapid increase in COVID-19 cases in India, the company is providing its voluntary licensing partners with technical assistance, support for the addition of new local manufacturing facilities and the donation of active pharmaceutical ingredient (API) to rapidly scale up production of remdesivir. Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and children hospitalized with severe disease.

Glenmark  Pharmaceuticals  Limited,  a  research-led,  global  integrated pharmaceutical company, is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 countries in the European Union.

About Author
Vinay Kumar Singh.  
Head-Formulation
Kumar Organic Products Research Centre Pvt. Ltd.,
Bengaluru

Natco Pharma Limited has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir Capsules for the treatment of COVID-19 positive patients.

Syngene International, an integrated research, development and manufacturing services company, announced that it has extended its ongoing research collaboration with Bristol Myers Squibb. The collaboration has been extended through the end of 2030 and will expand the breadth of drug discovery research conducted, including chemistry, biology, drug metabolism and pharmacokinetics, as well as translational medicine research and pharmaceutical development, including chemical process development and analytical sciences, in the coming years.

Walk in Interview (Novel Corona Virus (Covid - 19) It is therefore announced that, in order to meet the status of Novel Corona Virus (Covid 19), management of Anand District Hospitals and Covid Care Centers and treatment of Corona Virus sufferers below.  The said posts have to be filled for three months with fixed honorarium.

Post : Junior Pharmacist

The Tata Memorial Centre (TMC) is a Comprehensive Cancer Centre with a mission to achieve the highest standards in patient care, cancer prevention, cancer research and professional development for oncology and allied disciplines. TMC is an autonomous body funded, controlled by the Department of Atomic Energy, Government of India.

Northern Railway, the Jewel Set in the Crown of Indian Railways, has embarked on the mission to vanquish distances and create its own metaphor of existence. Formally established in the year 1952, it remains the largest zone in terms of route Kilometers, even after the re-organization of the Indian Railways into 16 zones. Northern Railway now comprises of 5 Divisions-Ambala, Delhi, Ferozpur, Lucknow and Moradabad.

National Institute of Malaria Research (NIMR) was established in 1977 as ‘Malaria Research Centre’, which was renamed as ‘National Institute of Malaria Research’ in November 2005. NIMR is one of the institutes of the Indian Council of Medical Research (an autonomous body under Department of Health Research, Ministry of Health & Family Welfare, Govt. of India).

National Institute of Biomedical Genomics (NIBMG) Kalyani is an Institute of Government of India, Ministry of Science & Technology, Department of Biotechnology. The Institute has created necessary physical infrastructure and critical platform technologies to support research, translation and training in biomedical genomics.

Ipca has been partnering healthcare globally in over 110 countries and in markets as diverse as Africa, Asia, Australia, Europe and the US. Ipca is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments.

Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Emcure Pharmaceuticals Private Limited on April 16, 1981 as a private limited company under the Companies Act, 1956. Our name embodies our purpose and core belief of the entire company which is to make Effective Medicine to Cure patients for enabling them to lead healthier lives.

A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus  MERS-CoV developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate models when given intradermally in abbreviated, low-dose immunization regimen. A similar vaccine candidate was previously shown to be safe and tolerable with a three-dose intramuscular injection regimen in a recently completed human phase 1 study and is currently in expanded studies of phase 1/2a trial.

LEO Pharma A/S, a global leader in medical dermatology announced that the Committee for Medicinal Products for Human Use  of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing authorization of Adtralza (tralokinumab) for the treatment of moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic therapy.

US-India Strategic Partnership Forum and members appreciate the efforts by leaders across the U.S. government at the highest level to identify concrete steps the United States can take to assist India through this crisis. The company looks forward to announcements soon that will support India’s efforts to fill needs like oxygen, medicines, medical supplies, and vaccines. This should include a waiver of current restrictions on the export of vaccine raw materials to ensure production of vaccine in India can continue uninterrupted.